These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 39243728)
1. Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy. Mitchell MP; Shaitelman SF; Smith BD; Krishnamurthy S; Valero V; Rauch GM; Shen Y; Lin H; Kuerer HM Eur J Surg Oncol; 2024 Dec; 50(12):108613. PubMed ID: 39243728 [TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer. van der Voort A; van der Hoogt KJJ; Wessels R; Schipper RJ; Wesseling J; Sonke GS; Mann RM Eur Radiol; 2024 Dec; 34(12):7994-8004. PubMed ID: 38967659 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy. Stjepanovic N; Kumar S; Jerzak KJ; Trudeau M; Warner E; Cao X; Eisen A; Tran W; Pezo RC Clin Breast Cancer; 2024 Dec; 24(8):e723-e730. PubMed ID: 39244392 [TBL] [Abstract][Full Text] [Related]
5. Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials. Fernandez-Martinez A; Rediti M; Tang G; Pascual T; Hoadley KA; Venet D; Rashid NU; Spears PA; Islam MN; El-Abed S; Bliss J; Lambertini M; Di Cosimo S; Huobe J; Goerlitz D; Hu R; Lucas PC; Swain SM; Sotiriou C; Perou CM; Carey LA JAMA Oncol; 2024 May; 10(5):603-611. PubMed ID: 38546612 [TBL] [Abstract][Full Text] [Related]
6. Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy. Peery GB; Pak J; Burkbauer L; Agala CB; Selfridge JM; Gallagher KK; Spanheimer PM J Surg Res; 2023 Dec; 292():247-257. PubMed ID: 37660548 [TBL] [Abstract][Full Text] [Related]
7. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean. Horey D; Kealy M; Davey MA; Small R; Crowther CA Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547 [TBL] [Abstract][Full Text] [Related]
8. Axillary Lymph Node Dissection versus Loco-regional Radiotherapy in Management of the Axilla in Node-Negative Locally Advanced Breast Cancer Post Neoadjuvant Chemotherapy. Ebrahim AK; Lasheen O; Mokhtar S; Lasheen S; Hassan M; Khallaf E Chirurgia (Bucur); 2024 Oct; 119(Ahead of print):1-12. PubMed ID: 39520209 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730 [TBL] [Abstract][Full Text] [Related]
10. Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study. Gentile D; Martorana F; Karakatsanis A; Caruso F; Caruso M; Castiglione G; Di Grazia A; Pane F; Rizzo A; Vigneri P; Tinterri C; Catanuto G Eur J Surg Oncol; 2024 Dec; 50(12):108732. PubMed ID: 39362047 [TBL] [Abstract][Full Text] [Related]
12. Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study. Wang SM; Li Y; Nash A; Ren Y; Thomas SM; Francescatti AB; Barber A; Lynch T; Frank ES; Grimm LJ; Thompson AM; Partridge AH; Hyslop T; Hwang ES; Ryser MD Br J Surg; 2024 Aug; 111(9):. PubMed ID: 39213131 [TBL] [Abstract][Full Text] [Related]
13. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
15. Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimization. Gennaro M; Mariani L; Palassini E; Stacchiotti S; Sangalli C; Listorti C; Vingiani A; Cortinovis U; Collini P; Allajbej A; Fiore M; Casali PG; Folli S; Gronchi A Eur J Surg Oncol; 2024 Dec; 50(12):108699. PubMed ID: 39326303 [TBL] [Abstract][Full Text] [Related]
16. Hip Transposition Can Provide Early Walking Function After Periacetabular Tumor Resection: A Multicenter Study. Zhang L; Iwata S; Saito M; Nakagawa M; Tsukushi S; Yoshida S; Gokita T; Ae K; Nakashima S; Watanuki M; Akiyama T Clin Orthop Relat Res; 2023 Dec; 481(12):2406-2416. PubMed ID: 37184605 [TBL] [Abstract][Full Text] [Related]
17. De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial. Chen XC; Jiao DC; Qiao JH; Wang CZ; Sun XF; Lu ZD; Li LF; Zhang CJ; Yan M; Wei Y; Chen B; Feng YQ; Deng M; Ma MD; Plichta JK; He YW; Liu ZZ Lancet Oncol; 2024 Nov; ():. PubMed ID: 39612919 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen for adults with hepatocellular carcinoma. Naing C; Ni H; Aung HH Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750 [TBL] [Abstract][Full Text] [Related]
19. Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study. Chen X; Cai Q; Deng L; Chen M; Xu M; Chen L; Lin Y; Li Y; Wang Y; Chen H; Liu S; Wu J; Tong X; Fu F; Wang C Front Immunol; 2024; 15():1465862. PubMed ID: 39628488 [TBL] [Abstract][Full Text] [Related]
20. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]